Research ExplorerPublicationsThe detection of oral pre- malignant lesions with an autoflu...

The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation

Standard

The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation. / Hanken, Henning; Kraatz, Juliane; Smeets, Ralf; Heiland, Max; Assaf, Alexandre Thomas; Blessmann, Marco; Eichhorn, Wolfgang; Clauditz, Till Sebastian; Gröbe, Alexander; Kolk, Andreas; Rana, Madiha.

In: HEAD FACE MED, Vol. 9, 01.01.2013, p. 23.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Hanken, H, Kraatz, J, Smeets, R, Heiland, M, Assaf, AT, Blessmann, M, Eichhorn, W, Clauditz, TS, Gröbe, A, Kolk, A & Rana, M 2013, 'The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation', HEAD FACE MED, vol. 9, pp. 23. https://doi.org/10.1186/1746-160X-9-23, https://doi.org/10.1186/1746-160X-9-26

APA

Hanken, H., Kraatz, J., Smeets, R., Heiland, M., Assaf, A. T., Blessmann, M., Eichhorn, W., Clauditz, T. S., Gröbe, A., Kolk, A., & Rana, M. (2013). The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation. HEAD FACE MED, 9, 23. https://doi.org/10.1186/1746-160X-9-23, https://doi.org/10.1186/1746-160X-9-26

Vancouver

Hanken H, Kraatz J, Smeets R, Heiland M, Assaf AT, Blessmann M et al. The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation. HEAD FACE MED. 2013 Jan 1;9:23. https://doi.org/10.1186/1746-160X-9-23, https://doi.org/10.1186/1746-160X-9-26

Bibtex

@article{088c210d2c5143e48a5ce961a343ed72,
title = "The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope{\texttrademark}) - a single blinded clinical evaluation",
abstract = "OBJECTIVE: The disease specific five-year survival rate especially for patients with advanced oral cancer has not improved significantly over the period of time. The most effective way of combating this dilemma is an early detection, diagnosis and eradication of early-stage lesions and their precursors. The use of VELscope{\textregistered} using an autofluorescence as a diagnostic tool might be useful in early detection of oral malignant lesions.MATERIALS AND METHODS: 120 patients with suspicious oral premalignant lesions were examined with two examination methods. They were randomly divided into two groups. Group 1 was examined conventional with white-light and group 2 was examined additionally to the white-light-examination with an autofluorescence visualization device, VELscope{\textregistered}. Biopsies were obtained from all suspicious areas identified in both examination groups (n = 52). The diagnostic strategies were compared regarding sensitivity and specificity.RESULTS: Based upon the result, use of the VELscope{\textregistered} leads to a higher sensitivity (22.0%), but regarding specificity the additional use of the VELscope{\textregistered} is inferior (8.4%).CONCLUSION: The VELscope device is a simple, non-invasive test of the oral mucosa, which can help the experienced clinician to find oral precursor malignant lesions.",
author = "Henning Hanken and Juliane Kraatz and Ralf Smeets and Max Heiland and Assaf, {Alexandre Thomas} and Marco Blessmann and Wolfgang Eichhorn and Clauditz, {Till Sebastian} and Alexander Gr{\"o}be and Andreas Kolk and Madiha Rana",
note = "Arbeit ist doppelt gelistet, als Original und titelgleich als Erratum, da der Autor Assaf {"}vergessen{"} wurde. Das Erratum listet Assaf als Autor. ",
year = "2013",
month = jan,
day = "1",
doi = "10.1186/1746-160X-9-23",
language = "English",
volume = "9",
pages = "23",
journal = "HEAD FACE MED",
issn = "1746-160X",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation

AU - Hanken, Henning

AU - Kraatz, Juliane

AU - Smeets, Ralf

AU - Heiland, Max

AU - Assaf, Alexandre Thomas

AU - Blessmann, Marco

AU - Eichhorn, Wolfgang

AU - Clauditz, Till Sebastian

AU - Gröbe, Alexander

AU - Kolk, Andreas

AU - Rana, Madiha

N1 - Arbeit ist doppelt gelistet, als Original und titelgleich als Erratum, da der Autor Assaf "vergessen" wurde. Das Erratum listet Assaf als Autor.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - OBJECTIVE: The disease specific five-year survival rate especially for patients with advanced oral cancer has not improved significantly over the period of time. The most effective way of combating this dilemma is an early detection, diagnosis and eradication of early-stage lesions and their precursors. The use of VELscope® using an autofluorescence as a diagnostic tool might be useful in early detection of oral malignant lesions.MATERIALS AND METHODS: 120 patients with suspicious oral premalignant lesions were examined with two examination methods. They were randomly divided into two groups. Group 1 was examined conventional with white-light and group 2 was examined additionally to the white-light-examination with an autofluorescence visualization device, VELscope®. Biopsies were obtained from all suspicious areas identified in both examination groups (n = 52). The diagnostic strategies were compared regarding sensitivity and specificity.RESULTS: Based upon the result, use of the VELscope® leads to a higher sensitivity (22.0%), but regarding specificity the additional use of the VELscope® is inferior (8.4%).CONCLUSION: The VELscope device is a simple, non-invasive test of the oral mucosa, which can help the experienced clinician to find oral precursor malignant lesions.

AB - OBJECTIVE: The disease specific five-year survival rate especially for patients with advanced oral cancer has not improved significantly over the period of time. The most effective way of combating this dilemma is an early detection, diagnosis and eradication of early-stage lesions and their precursors. The use of VELscope® using an autofluorescence as a diagnostic tool might be useful in early detection of oral malignant lesions.MATERIALS AND METHODS: 120 patients with suspicious oral premalignant lesions were examined with two examination methods. They were randomly divided into two groups. Group 1 was examined conventional with white-light and group 2 was examined additionally to the white-light-examination with an autofluorescence visualization device, VELscope®. Biopsies were obtained from all suspicious areas identified in both examination groups (n = 52). The diagnostic strategies were compared regarding sensitivity and specificity.RESULTS: Based upon the result, use of the VELscope® leads to a higher sensitivity (22.0%), but regarding specificity the additional use of the VELscope® is inferior (8.4%).CONCLUSION: The VELscope device is a simple, non-invasive test of the oral mucosa, which can help the experienced clinician to find oral precursor malignant lesions.

U2 - 10.1186/1746-160X-9-23

DO - 10.1186/1746-160X-9-23

M3 - SCORING: Journal article

C2 - 23967796

VL - 9

SP - 23

JO - HEAD FACE MED

JF - HEAD FACE MED

SN - 1746-160X

ER -